This inventor holds 2 USPTO granted patents. Top assignees: Ciba-Geigy Corporation, Novartis Corporation. Active years: 1997-1998.
Company Filing History:
Years Active: 1997-1998
Title: The Innovative Contributions of Urs Regenass
Introduction
Urs Regenass is a notable inventor based in Ettingen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at combating multi-drug resistance and tumor diseases. With a total of 2 patents, his work has the potential to impact cancer treatment and HIV-related therapies.
Latest Patents
Regenass's latest patents include innovative approaches such as "Carbazole derivatives as agents against multi-drug resistance" and "Use of compositions for combating tumour diseases." These inventions focus on the use of inhibitors of HIV aspartate proteases, including HIV-1 and HIV-2 proteases, and their salts. His research emphasizes the development of pharmaceutical compositions intended for the prophylaxis and treatment of tumor diseases, particularly those tumors that do not respond to traditional treatments.
Career Highlights
Throughout his career, Urs Regenass has worked with prominent companies in the pharmaceutical industry, including Ciba-Geigy Corporation and Novartis Corporation. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that address critical health challenges.
Collaborations
Regenass has collaborated with esteemed colleagues such as Oskar Wacker and Giorgio Caravatti. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Urs Regenass's innovative work in the pharmaceutical field showcases his commitment to addressing significant health issues through research and invention. His contributions have the potential to enhance treatment options for patients facing multi-drug resistance and tumor diseases.